5/13/2025  10:15:54 PM Chg. -5.43 Volume Bid5/13/2025 Ask5/13/2025 Market Capitalization Dividend Y. P/E Ratio
148.77USD -3.52% 416,869
Turnover: 62.2 mill.
148.03Bid Size: 100 148.55Ask Size: 100 357.16 bill.USD 3.31% 25.42

Business description

Johnson & Johnson and its subsidiaries (the "Company") have employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 250 operating companies conducting business in virtually all countries of the world. The Company’s primary focus is products related to human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
 

Management board & Supervisory board

CEO
Joaquin Duato
Management board
Joseph J. Wolk, Vanessa Broadhurst, Liz Forminard, Kristen Mulholland, John C. Reed, Tim Schmid, James Swanson, Jennifer L. Taubert, Kathryn E. Wengel
Supervisory board
Joaquin Duato, Darius Adamczyk, Mary C. Beckerle, Jennifer A. Doudna, Marillyn A. Hewson, Paula A. Johnson, Hubert Joly, Mark B. McClellan, Anne M. Mulcahy, Mark A. Weinberger, Nadja Y. West, Eugene A. Woods
 

Company data

Name: Johnson & Johnson
Address: One Johnson & Johnson Plaza,,New Brunswick, New Jersey 08933, USA
Phone: +1-732-524-2455
Fax: -
E-mail: -
Internet: www.jnj.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 77.97%
IPO date: 9/24/1944

Investor relations

Name: -
IR phone: +1-800-950-5089
IR Fax: -
IR e-mail: investor-relations@its.jnj.com

Main Shareholders

Others
 
65.69%
Vanguard Group Inc
 
9.67%
Blackrock Inc.
 
8.36%
State Street Corporation
 
5.58%
Geode Capital Management, LLC
 
2.40%
Morgan Stanley
 
1.82%
JP Morgan Chase & Company
 
1.61%
State Farm Mutual Automobile Insurance Co
 
1.32%
Northern Trust Corporation
 
1.28%
Others
 
2.27%